IP Library Granted Patent US 8,420,892
Granted Patent B2
US 8,420,892 · App. 12/725,482 · Granted Apr 16, 2013

Delta-9 elongases and their use in making polyunsaturated fatty acids

Inventors: Howard Glenn Damude (Hockessin, DE); Brian McGonigle (Wilmington, DE); Quinn Qun Zhu (West Chester, PA); Zhixiong Xue (Chadds Ford, PA)
Assignee: E. I. du Pont de Nemours and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,892
App. No.
12/725,482
Granted
Apr 16, 2013
Kind
B2
Abstract

Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-9 elongases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these delta-9 elongases in plants.

Claims (15)

1. A recombinant construct comprising an isolated polynucleotide comprising:

(a) a nucleotide sequence encoding a polypeptide having delta-9 elongase activity, wherein the polypeptide has at least 95% amino acid identity, based on the Clustal V method of alignment, when compared to an amino acid sequence as set forth in SEQ ID NO:5;

(b) a nucleotide sequence encoding a polypeptide having delta-9 elongase activity, wherein the nucleotide sequence has at least 95% sequence identity, based on the BLASTN method of alignment, when compared to a nucleotide sequence as set forth in SEQ ID NO:4 or SEQ ID NO:90; or

(c) a complement of the nucleotide sequence of (a) or (b) wherein the complement and the nucleotide sequence consist of the same number of nucleotides and are 100% complementary;

wherein said isolated polynucleotide of (a) or (b) is operably linked to at least one regulatory sequence.

2. A method for producing a transgenic plant comprising transforming a plant cell with the recombinant construct of claim 1 and regenerating a transgenic plant from the transformed plant cell.

3. The method of claim 2 wherein the transgenic plant is a soybean plant.

4. A transgenic seed comprising the recombinant construct of claim 1 .

5. A transgenic seed obtained from the plant made by the method of claim 2 or 3 .

6. An oilseed plant comprising the recombinant construct of claim 1 .

7. The oilseed plant of claim 6 , wherein the oilseed plant is selected from the group consisting of soybean, Brassica species, sunflower, maize, cotton, flax and safflower.

8. A seed obtained from the oilseed plant of claim 6 , wherein said seed comprises the recombinant construct.

9. Progeny plants obtained from the transgenic seed of claim 4 , wherein said plants comprise the recombinant construct.

10. Progeny plants obtained from the transgenic seed of claim 5 , wherein said plants comprise the recombinant construct.

11. Progeny plants obtained from the seed of claim 8 , wherein said plants comprise the recombinant construct.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 29, 2022
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 063141/0155 →
Continuity (3)
Division 11601563 · Nov 16, 2006
Provisional Application 60739989 · Nov 23, 2005
Related Publication 20100175148A1 · Jul 8, 2010